EZZ Life Science

EZZ Life Science Holdings Limited is a publicly traded genomic life science company headquartered in Silverwater, New South Wales, Australia, founded in 2019 and listed on the Australian Securities Exchange under the ticker symbol EZZ. The company has a mission to improve quality of life and human health through a focus on genomic research and deve... lopment to address four key human health challenges: genetic longevity, human papillomavirus, helicobacter pylori, and weight management. EZZ is at the forefront of delivering premium, science-backed health and wellness products, driven by a strong foundation in research and innovation. Through a dynamic omnichannel strategy spanning Australia, New Zealand, China and other global markets, the company is revolutionizing access to and engagement with cutting-edge health solutions, enabling consumers to take control of their health and longevity. EZZ operates two distinct and synergistic business models: a wholesale distribution model for the EAORON branded products in the skin care segment, and an integrated model including development, production and distribution for the EZZ branded products in the consumer health segment. The company is the exclusive wholesale distributor of EAORON's premium skincare solutions in Australia and New Zealand, offering over 20 products that nourish, protect, and revitalize skin. In 2025, EZZ launched its US-market brand, EZZDAY, manufactured entirely in the United States with advanced formulations to support immunity, energy, beauty, and everyday wellbeing. EZZ connects with consumers through wholesalers, retailers, e-commerce platforms, and social commerce channels, including livestream shopping programs with Chinese influencers. The company is led by Chair Glenn Cross, who brings four decades of life sciences experience including over 13 years as Chief Operating Officer and CEO of AusBiotech.Read More